2025 Year in Review
Thank you for being part of the Eloquest Healthcare Blog community throughout 2025! We’re grateful for your readership and hope our articles have informed, inspired, and strengthened your clinical practice. Below is a roundup of this year’s top-engaged posts. We invite you to revisit and share your favorites:
When CVC dressings fail, patients pay the price. The latest findings reveal how one simple addition—medical liquid adhesive—can make a measurable difference in dressing integrity. Curious what the STICKY Trial uncovered? Explore the key takeaways in ‘Staying Power Uncovering the Impact of Medical Liquid Adhesive on CVC Dressing Adherence in the ICU‘
What if a securement choice could reduce catheter dislodgement by more than 75%? The latest findings from the SECURED Trial highlight the powerful impact of advanced securement devices—and what nursing leaders can do to bridge the evidence-practice gap. In ‘Using Advanced Securement Devices to Decrease Risks to Patient Safety: New Research‘ see how SASS is reshaping patient safety.
Looking to strengthen CVC dressing adherence and reduce complications? Don’t miss our exclusive interview with Dr. Nicole Marsh, lead investigator of the award-winning STICKY Trial. She shares powerful insights on the role of gum mastic liquid adhesive in improving securement. Watch now and read the full study in ‘The STICKY Trial and the Impact of Gum Mastic Liquid Adhesive‘
In our “3 Questions With…” video series, we had the privilege of featuring Nancy Trick, Michael Stern, Kacey Wiseman, Leimomi Holmes, Melinda Webb, Nick Flaucher, Jedediah Gervacio and, Moira McErlean esteemed subject matter experts recognized for their leadership contributions, advocacy to the field of vascular access. Through engaging interviews, they provided valuable insights, discussed evidence-based practices, and recommended actionable solutions to address some of the most pressing questions and challenges in their respective areas of expertise. Their thought-provoking responses not only shed light on current issues but also inspire others to implement forward-thinking approaches.
As we head into 2026, we will continue sharing insights on advancements in clinical quality, patient safety, and HAI reduction. Subscribe to the Eloquest Healthcare Blog to stay informed with new contact throughout the year. For more information about Mastisol®, Detachol® and SecurAcath®, please contact your Eloquest Healthcare® sales consultant, or request a follow-up here.
